Journals / Türkiye Acil Tıp Dergisi / 2011 / Cilt: 11 - Sayı: 1

Current clinical management suggestions: emergency department management of a patient with acute diarrhea

Güncel klinik yaklaşım önerisi: acil serviste akut ishalli hastaya yaklaşım

Pages
33–39
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Reducing the intestinal colic by using ‘Hyoscine N-Butylbromide’ in patients with acute diarrhea: Recommendation Level C.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Providing medical care based on the current available evidence is a practice which can improve the service quality and protect physicians from potential legal problems.
📊
Key Findings & Data:The databases used to select the relevant articles were PubMed (since 1966), Cochrane Systematical Reviews and Cochrane Central Registered of Controlled Trials.
💡
Conclusion & Impact:Reducing the intestinal colic by using ‘Hyoscine N-Butylbromide’ in patients with acute diarrhea: Recommendation Level C.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Providing medical care based on the current available evidence is a practice which can improve the service quality and protect physicians from potential legal problems. In the present study, we aimed to determine the most suitable diagnostic and treatment modalities by reviewing the literature on the basis of current evidence in patients who present to the emergency department (ED) with acute diarrhea. Six clinical questions have been formulated before the literature review has been performed on this “Current Clinical Management Suggestions”. A literature review was conducted after the key words related to those clinical questions had been determined. The databases used to select the relevant articles were PubMed (since 1966), Cochrane Systematical Reviews and Cochrane Central Registered of Controlled Trials. The following findings were noted after the analyses: 1. Starting antibiotic therapy in patients presenting to the ED with acute diarrhea without considering the underlying cause: Recommendation Level B,2. Starting loperamide together with antibiotics in patients presenting to the ED with acute diarrhea: Recommendation Level A,3. Starting loperamide without initiating antibiotics in patients with acute diarrhea thought to be non-invasive: Recommendation Level B,4. Reducing the diarrhetic time by using “Saccharomyces Boulardii” in acute diarrhea: Recommendation Level C,5. Findings related to the existence of a positive culture in patients with acute diarrhea: a. Fever: Recommendation Level A, b. High CRP levels: Recommendation Level B, c. Bloody stool: Recommendation Level C,6. Reducing the intestinal colic by using ‘Hyoscine N-Butylbromide’ in patients with acute diarrhea: Recommendation Level C.

Özet

Hekimlerin mevcut güncel bilimsel kanıtlar eşliğinde hasta bakması, hem hizmet kalitesine artıracak hem de hekimleri yasal problemlerden koruyacak bir yöntemdir. Bu makalede, acil servise akut ishal ile başvuran yetişkin hastalarda en uygun tetkik ve tedavi modalitelerini, literatür analizi yaparak güncel kanıtlar eşliğinde belirlemeyi amaçladık. Bu “Güncel Klinik Yaklaşım Önerisi” için literatür taraması yapılmadan önce ishal ile ilgili toplam altı adet klinik soru oluşturuldu. Klinik sorularla ilintili olan anahtar kelimeler belirlendikten sonra literatür taraması yapıldı. Literatür taramasında PubMed (1966’dan bu yana), Cochrane Systematical Reviews, Cochrane Central Registered of Controlled Trials veri tabanları kullanıldı. Analiz sonunda; 1. Acil servise akut ishalle başvuran hastalarda etkene bakılmaksızın antibiyotik başlanabilmesi konusunda; Tavsiye Düzeyi: B. 2. Acil servise akut ishalle başvuran hastalarda antibiyotik ile beraber loperamide kullanılabilmesi konusunda; Tavsiye Düzeyi: A. 3. İnvaziv olmadığı düşünülen ishalli hastalarda antibiyotik olmadan loperamide kullanımı konusunda: Tavsiye Düzeyi: B.4. Akut ishalde “Saccharomyces boulardii” kullanımının ishal süresini kısaltması konusunda; Tavsiye Düzeyi: C. 5. Akut ishalli hastalarda kültür pozitifliği ile ilişkili olan bulgular; a. Yüksek ateş: Tavsiye Düzeyi A. b. Yüksek CRP düzeyleri: Tavsiye Düzeyi B. c. Kanlı gaita: Tavsiye Düzeyi C.6. Hyoscine N-Butylbromide akut ishalli hastalarda etkili midir? Tavsiye Düzeyi: C,olarak saptandı.

🔖

Cite This Article

EKEN, C. (2022). Current clinical management suggestions: emergency department management of a patient with acute diarrhea. Türkiye Acil Tıp Dergisi, Cilt: 11 - Sayı: 1, 33–39. https://ajindex.com/articles/626014

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. http://www.tuik.gov.tr/VeriBilgi.do?tb_id=6&ust_id=1. (Erişim tarihi:28.03.2011). 2 http://emedicine.medscape.com/article/775277-overview. (Erişim tarihi:28.03.2011). 3. http://www.who.int/mediacentre/factsheets/fs330/en/index.html. (Erişim tarihi: 28.03.2011). 4. Ericsson CD, Johnson PC, Dupont HL, Morgan DR, Bitsura JA, de la Cabada FJ. Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers’ diarrhea. A placebo-controlled, randomized trial. Ann Intern Med 1987
  2. Noguerado A, Garcia-Polo I, Isasia T, Jimenez ML, Bermudez P, Pita J, et al. Early single dose therapy with ofloxacin for empirical treatment of acute gastroenteritis: a randomised, placebo-controlled double-blind clinical trial. J Antimicrob Chemother 1995
  3. Dryden MS, Gabb RJ, Wright SK. Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin. Clin Infect Dis 1996
  4. Taylor DN, Bourgeois AL, Ericsson CD, Steffen R, Jiang ZD, Halpern J, et al. A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers’ diarrhea. Am J Trop Med Hyg 2006
  5. Salam I, Katelaris P, Leigh-Smith S, Farthing MJ. Randomised trial of single-dose ciprofloxacin for travellers’ diarrhoea. Lancet Date of Publication 1994
  6. 344(8936):1537-9. 9. Salam I, Katelaris PH, Leigh-Smith S, et al. A prospecitve, randomised, placebo-controlled trial of single dose ciprofloxacin for the treatment of travellers’ diarrhoea. Gut Date of Publication. 1994
  7. 35(Suppl 2):S30. 10. Riddle MS, Arnold S, Tribble DR. Effect of adjunctive loperamide in combination with antibiotics on treatment outcomes in traveler’s diarrhea: a systematic review and meta-analysis. Clin Infect Dis 2008
  8. Kaplan MA, Prior MJ, Ash RR, McKonly KI, Helzner EC, Nelson EB. Loperamide-simethicone vs loperamide alone, simethicone alone, and placebo in the treatment of acute diarrhea with gas-related abdominal discomfort. A randomized controlled trial. Arch Fam Med 1999
  9. van Loon FP, Bennish ML, Speelman P, Butler C. Double blind trial of loperamide for treating acute watery diarrhoea in expatriates in Bangladesh. Gut 1989
  10. Dettmer A. Loperamide oxide in the treatment of acute diarrhea in adults. Clin Ther 1994
  11. Bergström T, Alestig K, Thorén K, Trollfors B. Symptomatic treatment of acute infectious diarrhoea: loperamide versus placebo in a double